ArticleNaunyn-Schmiedeberg's archives of pharmacology2012

(-)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury.

Waleed M Renno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.